Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SU... von Tabernero, J., Taieb, J., Fakih, M., Prager, G.W., Van Cutsem, E., Ciardiello, F., Mayer, R.J., Amellal, N., Skanji, D., Calleja, E., Yoshino, T.

Volltext

PIN3 Burden of Cytomegalovirus Disease in Immunosuppressed Persons Following Transplantation in France von Goryakin, Y, Ferchichi, S, Skanji, D, Odeyemi, I.I, Hakimi, Z, Aballea, S

Volltext

O-9 Health-related quality of life associated with trifluridine/tipiracil in combination with bevacizumab in refractory metastatic colorectal cancer: An analysis of the phase 3 SUN... von Prager, G., Taieb, J., Fakih, M., Ciardiello, F., Van Cutsem, E., Elez, E., Cruz, F., Wyrwicz, L., Stroyakovskiy, D., Pápai, Z., Poureau, P., Liposits, G., Cremolini, C., Bondarenko, I., Modest, D., Amellal, N., Hassan, H., Skanji, D., Tabernero, J.

Volltext

614P Effect of KRASG12 mutations on overall survival in patients with refractory metastatic colorectal cancer: A post-hoc analysis of the phase III SUNLIGHT trial von Tabernero, J., Prager, G., Fakih, M., Ciardiello, F., Van Cutsem, E., Elez Fernandez, M.E., Cruz, F.J.S.M., Wyrwicz, L.S., Stroyakovskiy, D., Pápai, Z., Martinelli, E., Salvatore, L., Poureau, P.G., Liposits, G., Cremolini, C., Modest, D.P., Causse-Amellal, N., Roby, L., Skanji, D., Taieb, J.

Volltext

Efficacy and safety of trifluridine/tipiracil (FTD/TPI) in European patients with heavily pretreated metastatic gastric cancer (mGC): An analysis of the TAGS study von Alsina, M., Tabernero, J., Arkenau, H.-T., Squadroni, M., Doi, T., Faustino, C., Ghidini, M., Mansoor, W., Shitara, K., Van Cutsem, E., Causse-Amellal, N., Leger, C., Skanji, D., Ilson, D.

Volltext

801PEfficacy and safety of trifluridine/tipiracil (FTD/TPI) in European patients with heavily pretreated metastatic gastric cancer (mGC): An analysis of the TAGS study von Alsina, M, Tabernero, J, Arkenau, H-T, Squadroni, M, Doi, T, Faustino, C, Ghidini, M, Mansoor, W, Shitara, K, Van Cutsem, E, Causse-Amellal, N, Leger, C, Skanji, D, Ilson, D

Volltext

801P - Efficacy and safety of trifluridine/tipiracil (FTD/TPI) in European patients with heavily pretreated metastatic gastric cancer (mGC): An analysis of the TAGS study von Alsina, M., Tabernero, J., Arkenau, H.-T., Squadroni, M., Doi, T., Faustino, C., Ghidini, M., Mansoor, W., Shitara, K., Van Cutsem, E., Causse-Amellal, N., Leger, C., Skanji, D., Ilson, D.

Volltext

Impact of KRAS G12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III S... von Tabernero, J, Taieb, J, Fakih, M, Prager, G W, Van Cutsem, E, Ciardiello, F, Mayer, R J, Amellal, N, Skanji, D, Calleja, E, Yoshino, T

Volltext

Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS von Tabernero, J, Alsina, M, Shitara, K, Doi, T, Dvorkin, M, Mansoor, W, Arkenau, H-T, Prokharau, A, Ghidini, M, Faustino, C, Gorbunova, V, Zhavrid, E, Nishikawa, K, Ando, T, Yalcin, S, Van Cutsem, E, Sabater, J, Skanji, D, Leger, C, Amellal, N, Ilson, DH

Volltext bestellen